Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Plumb, Ian D."'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gambia Pneumococcal Surveillance Group, Mackenzie, Grant A, Hill, Philip C, Jeffries, David J, Ndiaye, Malick, Sahito, Shah M, Hossain, Ilias, Uchendu, Uchendu, Ameh, David, Adeyemi, Oyedeji, Pathirana, Jayani, Olatunji, Yekini, Abatan, Baderinwa, Muhammad, Bilquees S, Ahameefula, Ebirim, Fombah, Augustin E, Adeshola, Banjo, Lobga, Babila G, Saha, Debasish, Mackenzie, Roslyn, Odutola, Aderonke, Plumb, Ian D, Akano, Aliu, Ebruke, Bernard E, Ideh, Readon C, Kuti, Bankole, Githua, Peter, Olutunde, Emmanuel, Ofordile, Ogochukwu, Green, Edward, Usuf, Effua, Badji, Henry, Ikumapayi, Usman Na, Manjang, Ahmed, Salaudeen, Rasheed, Nsekpong, E David, Jarju, Sheikh, Antonio, Martin, Sambou, Sana, Ceesay, Lamin, Lowe-Jallow, Yamundow, Fofana, Sidat, Jasseh, Momodou, Mulholland, Kim, Knoll, Maria, Levine, Orin S, Howie, Stephen R, Adegbola, Richard A, Greenwood, Brian M, Corrah, Tumani
BACKGROUND: The Gambia introduced seven-valent pneumococcal conjugate vaccine (PCV7) in August 2009, followed by PCV13 in May, 2011, using a schedule of three primary doses without a booster dose or catch-up immunisation. We aimed to assess the long-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::bcf61de39dc66dcd9090b69f4808b213
https://researchonline.lshtm.ac.uk/id/eprint/4661829/3/Gambia_etal_2021_Impact-of-the-introduction-of.pdf
https://researchonline.lshtm.ac.uk/id/eprint/4661829/3/Gambia_etal_2021_Impact-of-the-introduction-of.pdf
Autor:
Miller MJ; CDC COVID-19 Response, Post-COVID Conditions Team, U.S. Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop US10-1, Atlanta, GA, 30329-4027, USA; Chronic Viral Diseases Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging Zoonotic and Infectious Diseases, U.S. Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop US10-1, Atlanta, GA, 30329-4027, USA. Electronic address: yax6@cdc.gov., Feldstein LR; CDC COVID-19 Response, Post-COVID Conditions Team, U.S. Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop US10-1, Atlanta, GA, 30329-4027, USA; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop US10-1, Atlanta, GA, 30329-4027, USA. Electronic address: nqw5@cdc.gov., Holbrook J; Disability Science and Program Team, Division of Human Development and Disability, U.S. Centers for Disease Control and Prevention, National Center for Birth Defects and Developmental Disorders, 4770 Buford Hwy NE, Mailstop S106-4, Atlanta, GA, 30341-3717, USA. Electronic address: vzt4@cdc.gov., Plumb ID; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop US10-1, Atlanta, GA, 30329-4027, USA. Electronic address: ydk9@cdc.gov., Accorsi EK; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop US10-1, Atlanta, GA, 30329-4027, USA; Epidemic Intelligence Service, U.S. Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop US10-1, Atlanta, GA, 30329-4027, USA. Electronic address: vgi0@cdc.gov., Zhang QC; Disability Science and Program Team, Division of Human Development and Disability, U.S. Centers for Disease Control and Prevention, National Center for Birth Defects and Developmental Disorders, 4770 Buford Hwy NE, Mailstop S106-4, Atlanta, GA, 30341-3717, USA. Electronic address: gso9@cdc.gov., Cheng Q; Disability Science and Program Team, Division of Human Development and Disability, U.S. Centers for Disease Control and Prevention, National Center for Birth Defects and Developmental Disorders, 4770 Buford Hwy NE, Mailstop S106-4, Atlanta, GA, 30341-3717, USA. Electronic address: ycx6@cdc.gov., Ko JY; CDC COVID-19 Response, Post-COVID Conditions Team, U.S. Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop US10-1, Atlanta, GA, 30329-4027, USA; Division of Reproductive Health, National Center for Chronic Diseases Prevention and Health Promotion, U.S. Centers for Disease Control and Prevention, 4770 Buford Hwy NE, Mailstop S107-1, Atlanta, GA, 30341-3717, USA. Electronic address: fob1@cdc.gov., Wanga V; Child Development Studies Team, Division of Human Development and Disability, National Center on Birth Defects and Developmental Disabilities, U.S. Centers for Disease Control and Prevention, 4770 Buford Hwy S106-4, Atlanta, GA 30341-3717, USA; Epidemic Intelligence Service, U.S. Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop US10-1, Atlanta, GA, 30329-4027, USA. Electronic address: qdy0@cdc.gov., Konkle S; Epidemic Intelligence Service, U.S. Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop US10-1, Atlanta, GA, 30329-4027, USA. Electronic address: qdv8@cdc.gov., Dimitrov LV; Child Development Studies Team, Division of Human Development and Disability, National Center on Birth Defects and Developmental Disabilities, U.S. Centers for Disease Control and Prevention, 4770 Buford Hwy S106-4, Atlanta, GA 30341-3717, USA; Oak Ridge Institute for Science and Education, U.S. Centers for Disease Control and Prevention Research Participation Programs, P.O. Box 117, Oak Ridge, TN, 37831-0117, USA. Electronic address: qwj7@cdc.gov., Bertolli J; CDC COVID-19 Response, Post-COVID Conditions Team, U.S. Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop US10-1, Atlanta, GA, 30329-4027, USA; Chronic Viral Diseases Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging Zoonotic and Infectious Diseases, U.S. Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop US10-1, Atlanta, GA, 30329-4027, USA. Electronic address: jub7@cdc.gov., Saydah S; CDC COVID-19 Response, Post-COVID Conditions Team, U.S. Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop US10-1, Atlanta, GA, 30329-4027, USA; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop US10-1, Atlanta, GA, 30329-4027, USA. Electronic address: zle0@cdc.gov.
Publikováno v:
Disability and health journal [Disabil Health J] 2023 Apr; Vol. 16 (2), pp. 101436. Date of Electronic Publication: 2022 Dec 19.
Autor:
Shah MM; Coronavirus and Other Respiratory Viruses Division (proposed), National Center for Immunization and Respiratory Diseases, CDC, Verona, Wisconsin. Electronic address: bgn3@cdc.gov., Joyce B; Epic Research, Epic Systems Corporation, Verona, Wisconsin., Plumb ID; Coronavirus and Other Respiratory Viruses Division (proposed), National Center for Immunization and Respiratory Diseases, CDC, Verona, Wisconsin., Sahakian S; Epic Research, Epic Systems Corporation, Verona, Wisconsin., Feldstein LR; Coronavirus and Other Respiratory Viruses Division (proposed), National Center for Immunization and Respiratory Diseases, CDC, Verona, Wisconsin., Barkley E; Epic Research, Epic Systems Corporation, Verona, Wisconsin., Paccione M; Epic Research, Epic Systems Corporation, Verona, Wisconsin., Deckert J; Epic Research, Epic Systems Corporation, Verona, Wisconsin., Sandmann D; Epic Research, Epic Systems Corporation, Verona, Wisconsin., Gerhart JL; Epic Research, Epic Systems Corporation, Verona, Wisconsin., Hagen MB; Coronavirus and Other Respiratory Viruses Division (proposed), National Center for Immunization and Respiratory Diseases, CDC, Verona, Wisconsin.
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2023 Jan; Vol. 23 (1), pp. 150-155. Date of Electronic Publication: 2023 Jan 11.